Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

Rigosertib demonstrates considerable efficacy and safety in the treatment of advanced/metastatic cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa

#2024
#JOURNAL OF INVESTIGATIVE DERMATOLOGY

PMU Authors
M. Laimer, E. Mayr, J. Bauer

All Authors
M. Laimer, A. South, H. Y. Yang, L. Banner, E. Mayr, S. Kitzmueller, M. Parris, M. Arora, J. Bauer, N. Nikbakht

Journal association
JOURNAL OF INVESTIGATIVE DERMATOLOGY

Abstract

We are sorry. The full text is not available.